"Gold Nanoparticles Reverse Brain Deficits in MS and Parkinson's"
Phase two clinical trials at UT Southwestern Medical Center showed that a daily dose of gold nanocrystals significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements for patients with multiple sclerosis and Parkinson's disease. The nanocrystals, known as CNM-Au8, improved the NAD+/NADH ratio, positively altering brain cells' energy balance, and potentially ameliorating functional symptoms of the diseases. These findings could lead to a promising treatment for neurodegenerative conditions, but further studies are needed to confirm the results.